Osteogenic Neoplasm — Trials

Osteogenic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

357 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–29 of 29 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04616560	Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor	recruiting	Phase 2	55	National Cancer Institute (NCI)NIH	1	Sep 29, 2026	clinicaltrials
NCT06465199	Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas	recruiting	Phase 1 / Phase 2	265	Milton S. Hershey Medical CenterOTHER	1	Sep 3, 2026	clinicaltrials